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Abstract 21 
Objectives: To determine the prevalence of monochorionic monoamniotic (MCMA) twin 22 
pregnancies and to describe perinatal outcomes and clinical management of these 23 
pregnancies. 24 
Methods:  This multicentre cohort study used population-based data on MCMA twin 25 
pregnancies from 11 Northern Survey of Twin and Multiple Pregnancy (NorSTAMP) 26 
maternity units for the prevalence estimation of MCMA twinning. Pregnancy outcomes at 27 
<24 weeks’ gestation, antenatal parameters and perinatal outcomes (from ≥24 weeks to the 28 
first 28 days of life) were analysed using combined data on pregnancies with confirmed 29 
MCMA chorionicity from the NorSTAMP and the Southwest Thames Region of London 30 
Obstetric Research Collaborative (STORK) multiple pregnancy cohort for 2000-2013.  31 
Results: The estimated total prevalence of MCMA twin pregnancies in the North of England 32 
was 8.2 per 1000 total twin pregnancies, the birth prevalence was 0.08 per 1000 all (singleton 33 
and multiple) pregnancies. The rate of a spontaneous or iatrogenic fetal death at <24 weeks’ 34 
gestation was 31.8%; the overall perinatal mortality was 14.7%, ranging from 69.2% at <30 35 
weeks to 4.3% at 33-34 weeks’ gestation. MCMA twins who survived in utero beyond 24 36 
weeks were delivered, usually by caesarean section, at a median of 33 weeks of gestation 37 
(interquartile range=32-34). 38 
Conclusions: In MCMA twins surviving beyond 24 weeks of gestation, there was a higher 39 
survival rate compared to previous decades presumably due to early diagnosis, close 40 
surveillance and elective birth around 32-34 weeks of gestation. High perinatal mortality at 41 
early gestations was mainly attributed to extreme prematurity due to preterm spontaneous 42 
labour. 43 
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Introduction 44 
Monozygotic twinning is more stable than dizygotic twinning, similar across countries and 45 
little affected by factors such as fertility treatment, increasing maternal age and obesity, major 46 
contributors to the increased twinning rates in recent decades.1-3 Monochorionic (MC) twins 47 
(about 20% of all twins) are at a higher risk of perinatal death than dichorionic (DC) twins4-9 48 
due to higher prematurity rates, selective fetal growth restriction (sFGR), congenital 49 
anomalies and twin-twin transfusion syndrome (TTTS).10,11 MC monoamniotic (MCMA) 50 
twins that also share the same amniotic sac are rarer, occurring in about 5% of MC 51 
pregnancies, or in one in 10,000 all pregnancies.9 They carry an additional risk for perinatal 52 
death due to twin-related congenital anomalies and cord-related complications, resulting in 53 
about 15% of deaths after 20 weeks of pregnancy.12,13 Although the perinatal mortality of 54 
MCMA twins has strikingly reduced during the last two decades compared to extremely high 55 
rates up to 70% reported previously,14 it remains relatively high despite improved surveillance 56 
and care.12 57 
As MCMA twinning is very uncommon, randomised controlled evidence of the best 58 
management of MCMA twin pregnancies is lacking9 and, until recently, there were no 59 
consistent recommendations on the optimal timing or method of delivery.15 For example, the 60 
National Institute for Health and Clinical Excellence (NICE) guidance (England & Wales, 61 
2011) on the antenatal management of twin and triplet pregnancies highlighted that there was 62 
insufficient evidence for effective clinical management of MCMA twin pregnancies, and that 63 
there was need for further research to inform future provision of NHS services.15 There is 64 
some evidence from a recent multicentre cohort study,16 which supports the American 65 
College17 and Royal College10 of Obstetricians and Gynaecologists recommendations for 66 
delivery of MCMA twins by caesarean section at 32-34 weeks, but more studies of these rare 67 
multiple pregnancies are needed. 68 
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This collaborative study aimed: to determine the prevalence of MCMA twin pregnancies 69 
using population-based data from the Northern Survey of Twin and Multiple Pregnancy 70 
(NorSTAMP), 2000-2013, and to describe perinatal outcomes and clinical management of 71 
these pregnancies using data from the NorSTAMP and the Southwest Thames Region of 72 
London Obstetric Research Collaborative (STORK) multiple birth cohort.  73 
Methods 74 
Data sources and study population, 2000-2013 75 
The NorSTAMP (established in 1998, data collection ceased 31st March 2015) captured data 76 
on multiple pregnancies of women resident in the North of England (North East and North 77 
Cumbria), which has a population of around 3 million and 32,000 annual deliveries. The 78 
ascertainment was from the earliest antenatal scan at which a multiple pregnancy was 79 
diagnosed (recommended at 10–13 weeks in the UK18) and then at the 20-week routine 80 
ultrasound anomaly scan and at delivery (details of the notification system are presented 81 
elsewhere19,20). The records were maintained and held at the Regional Maternity Survey 82 
Office (RMSO), on a single database linked through the mother’s details to other RMSO 83 
registers, including the Northern Congenital Abnormality Survey (NorCAS).20 The RMSO 84 
data were annually cross-validated with the Office for National Statistics (ONS) birth and 85 
death data through the external linkage built into the database. The NorSTAMP collected data 86 
on maternal, obstetric and infant variables, including maternal age, index of multiple 87 
deprivation (IMD) score (an area-based measure of socio-economic position based on the 88 
maternal residential postcode, analysed in quintiles), pregnancy outcomes [spontaneous fetal 89 
loss (<16 completed weeks of gestation), selective feticide, miscarriage (16-23 weeks), 90 
termination of pregnancy (TOP), stillbirth (fetal death delivered at ≥24 weeks of gestation), 91 
early neonatal death (0-6 days of life), late neonatal death (7-27 days of life) and post-92 
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neonatal death (28-365 days of life), alive at 1 year] and chorionicity type. The final diagnosis 93 
of chorionicity for like-sex twin pregnancies is based on placental examination and histology, 94 
and where unavailable, on the appropriate first trimester ultrasound determination. 95 
Chorionicity diagnosis was verified and detailed antenatal data were obtained from the serial 96 
ultrasound scans in the Department of Fetal Medicine database of the Royal Victoria 97 
Infirmary (RVI), the regional tertiary centre in Newcastle upon Tyne. Information on zygosity 98 
as well as type of conception is not recorded in the NorSTAMP.20 Anonymised data on 99 
neonatal morbidity and care were obtained from the RVI Special Care Baby Unit (SCBU) 100 
database after the linkage with obstetric ultrasound records. 101 
The STORK multiple pregnancy cohort covers multiple pregnancies registered for routine 102 
antenatal care in ten hospitals (46,500 annual births) and collects matched data on antenatal 103 
care, including ultrasound scan, and pregnancy outcomes from two computer databases.21 The 104 
STORK regional hospitals, including the tertiary hospital St George’s University of London 105 
(SGH), had unified protocols for antenatal management. Ultrasound scans were performed 106 
every two weeks from 16 weeks until the end of the pregnancy, which included assessment of 107 
fetal biometry, amniotic fluid volume and umbilical artery Doppler waveforms. Routine 108 
antenatal admission for fetal monitoring was not advocated as these pregnancies were 109 
managed as outpatient, and were admitted for obstetric indications mainly. Neonatal outcome 110 
data were collected from the SGH and other STORK hospitals where possible.  111 
All maternity units in both the NorSTAMP and STORK cohorts follow the 2011 NICE 112 
recommendations for the antenatal management of twin and triplet pregnancies.15 The North 113 
of England regional guidance, agreed and implemented in 2009, is consistent with the NICE 114 
principles.22 Those units that do not have a nominated multidisciplinary team for management 115 
of MCMA twin pregnancy referred these patients to the RVI where closer fetal surveillance 116 
was undertaken at ≥24 weeks. Routine practice for management of MCMA pregnancies in 117 
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both RVI and STORK centres was similar in relation to frequency of ultrasound scans 118 
(fortnightly from 16 weeks of gestation for uncomplicated pregnancies or more frequently 119 
from 24 weeks, if necessary) and prescription of a course of corticosteroids for fetal lung 120 
maturation before elective caesarean section at about 32-34 weeks of gestation. However, in 121 
contrast to the management of MCMA pregnancies as outpatients in the STORK cohort, the 122 
RVI followed the principles of active management which would offer admission to an 123 
antenatal ward, computerised cardiotocograms (CTGs) three times a day, weekly ultrasound 124 
scans for Doppler measurements with fetal biometry every two weeks (Figure S1). The timing 125 
of active management differs for different patients depending on the gestation at which 126 
patients would opt for elective delivery if there were concerns about fetal wellbeing, but 127 
usually from 28 weeks. 128 
Inclusion criteria and Definitions  129 
Only twin pregnancies with a definite diagnosis of MCMA chorionicity were included in both 130 
cohorts. An initial NorSTAMP cohort was refined by excluding confirmed MCDA 131 
pregnancies and complemented by additional MCMA pregnancies identified in the RVI 132 
ultrasound database. Women who refused to give consent for their confidential data to be held 133 
in the NorSTAMP were excluded from the analyses of antenatal and neonatal data (n=6, 134 
Figure 1). Neonatal death was defined as death during the first 0-27 days after live birth. 135 
Perinatal death included both stillbirth (fetal death at ≥24 weeks’ gestation) and neonatal 136 
death. Twin maternities were defined as pregnancies resulting in at least one live birth or 137 
stillbirth and were used for the population-based birth prevalence estimation and for the 138 
calculation of perinatal mortality. 139 
The following indicators of fetal growth and wellbeing/development were recorded and 140 
analysed: sFGR [(fetal size discordance defined as difference in estimated fetal weight, EFW, 141 
(using Hadlock formula) at the last scan before delivery of >20%];10 inter-twin birthweight 142 
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discordance (defined as difference in birthweight of >20%); small for gestational age (SGA) 143 
at birth (defined as birthweight <10th percentile using birthweight-by-gestation and sex 144 
standards from a population of Scottish twins23); EFW-based SGA (defined as EFW <10th 145 
percentile using fetal growth curves from the USA ultrasound data24 adjusted to fit the 146 
Scottish reference dataset23 following our previously used approach25). Other variables 147 
included diagnosis of cord entanglement, TTTS, twin reversed arterial perfusion (TRAP) 148 
sequence, evidence of abnormal umbilical artery Doppler (pulsatility index >95th centile, 149 
absent or reversed end-diastolic flow) at the last ultrasound scan within two weeks before 150 
delivery and congenital anomaly diagnosed prenatally. 151 
Data on the following neonatal outcomes were collected for infants who survived the neonatal 152 
period: respiratory distress syndrome (RDS) (yes/no), necrotising enterocolitis (yes/no), 153 
intraventricular haemorrhage (yes/no), congenital anomalies (yes/no, and if yes, final 154 
diagnosis), sepsis (yes/no), admission to SCBU (yes/no, if yes, number of days), mechanical 155 
ventilation (yes/no, if yes, number of days), continuous positive airway pressure (CPAP). 156 
The North of England data on congenital anomalies were obtained from the NorCAS, a 157 
member of the European Surveillance of Congenital Anomalies (EUROCAT). NorCAS 158 
collects data on major congenital anomalies (up to six individual congenital anomalies per 159 
case) occurring in late miscarriages (20-23 weeks gestation), termination of pregnancy (TOP) 160 
for fetal anomaly (any gestation), stillbirths or live births, whether diagnosed antenatally or 161 
not.26 Cases are notified from multiple sources and are included when first diagnosed at any 162 
age up to 12 years.26 All major congenital anomalies were coded according to the WHO 163 
International Classification of Diseases 10th Revision (ICD-1027) and categorised using the 164 
EUROCAT criteria into group (the organ system affected), subtype (the specific condition) 165 
and syndrome.28,29 Cases with more than one ICD code were assigned a primary diagnosis 166 
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using a hierarchical approach described elsewhere.30 Congenital anomalies in the STORK 167 
cohort were recorded based on ultrasound scan diagnosis confirmed at birth. 168 
Statistical analysis 169 
The MCMA twin birth prevalence for 2000-2013 was estimated as the number of MCMA 170 
twin maternities for the North of England population per 1000 total pregnancies resulting in 171 
registered births (live or stillbirths) obtained from the ONS. The total prevalence was 172 
estimated using the number of all MCMA twin pregnancies per 1000 all twin pregnancies 173 
recorded in NorSTAMP. Descriptive statistics were used to characterise and compare baseline 174 
characteristics of MCMA twin pregnancies between the NorSTAMP and STORK cohorts. 175 
Differences in the distributions of continuous variables were compared using Mann-Whitney 176 
U test and medians with interquartile ranges (IQR) were reported. Percentages were presented 177 
for categorical variables and compared using the Χ2 test (Fisher exact test). Perinatal mortality 178 
was calculated using combined NorSTAMP and STORK data per 1000 individuals from 179 
MCMA maternities, including those with one fetal loss before 24 weeks gestation. Antenatal 180 
parameters and obstetric outcomes were analysed using data for stillbirths and live births, 181 
while the analysis of neonatal outcomes was restricted to neonatal survivors. 182 
All analyses were performed using SPSS Statistics for Windows, version 21.0 (Armonk, NY: 183 
IBM Corp). P <0.05 was considered statistically significant. 184 
Results 185 
Prevalence of MCMA twin pregnancies (NorSTAMP, n=59 twin pregnancies) 186 
Overall, there were 59 twin pregnancies in the North of England during 2000-2013, with 187 
MCMA chorionicity confirmed by either both ultrasound scan and placental pathology 188 
(54.2%), where available, or by the first trimester ultrasound scan only (45.8%), including 189 
pregnancies resulting in early fetal losses of both co-twins (n=22) (Figure 1). The estimated 190 
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MCMA birth prevalence was 0.08 (37/442,624) per 1000 total pregnancies (singleton and 191 
multiple), or 5.7 (37/6536) per 1000 twin pregnancies, resulting in registered births. The total 192 
prevalence was 8.2 per 1000 total twin pregnancies (59/7170) (Figure 1).  193 
Pregnancy outcomes of MCMA twin pregnancies (NorSTAMP and STORK, n=85 194 
pregnancies) 195 
Table 1 shows baseline characteristics for 85 MCMA pregnancies (excluding conjoined 196 
twins) from the NorSTAMP and STORK cohorts. There were no significant differences in 197 
median maternal BMI at booking, as well as the percentage of nulliparous women, prenatal 198 
diagnosis of chorionicity or deliveries by caesarean section between the two cohorts. 199 
However, the mothers were older and the percentage of pregnancies with female fetal sex was 200 
significantly higher in the STORK cohort, while the percentage of women living in the most 201 
deprived areas (5th quintile) was significantly higher in the NorSTAMP cohort (Table 1).  202 
Tables 2a and b show pregnancy outcomes for these 85 pregnancies. Thirty pregnancies 203 
resulted in a spontaneous or iatrogenic intrauterine death (IUD) before 24 weeks gestation 204 
(IUD rate 31.8%): spontaneous IUD (n=17) or TOP (n=7) of both fetuses, and six with either 205 
a spontaneous IUD (n=3) or selective termination (n=3) (Table 2a). Among further 55 206 
pregnancies, the majority (n=49) were both live births [in 43 (88%) both survived the 207 
neonatal period], while six resulted in either a single or double IUD at ≥24 weeks (Table 2b).  208 
Perinatal mortality in MCMA twins (NorSTAMP and STORK, n=116 registered twin births) 209 
Table 3 shows stillbirth and neonatal mortality among MCMA twins with known causes of 210 
death. The overall perinatal mortality was 14.7% differing by gestational age windows: 211 
69.82%, 11.8%, 4.3% and 4.8% at <30 weeks, 30-32, 33-34 and ≥35weeks of gestation 212 
respectively. The excess perinatal mortality at <30 weeks was mainly attributed to neonatal 213 
deaths due to extreme prematurity as a result of spontaneous labour at 22-26 weeks (n=6, 214 
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among those one twin with complex congenital heart defect) and antepartum stillbirths at 24 215 
and 27 weeks (n=3). According to the post-mortem examination, antepartum hypoxia was the 216 
leading cause of stillbirth (3/8 due to presumed cord entanglement) with double IUDs in two 217 
pregnancies (Tables 2 and 3). 218 
Antenatal parameters and obstetric outcomes of MCMA twins (NorSTAMP and STORK, n=45 219 
pregnancies)  220 
Figure 1 shows the derivation of the cohort eligible for the analysis of MCMA pregnancies 221 
that survived beyond 24 weeks’ gestation. Table 4 shows antenatal indicators of fetal 222 
development and wellbeing, and obstetric outcomes for live and stillborn MCMA twins, 223 
whose mothers gave consent for their confidential data to be held in the NorSTAMP. In over 224 
two thirds (33/45, 73.3%) of pregnancies, MCMA placentation was diagnosed in the first 225 
trimester of pregnancy (≤13 weeks gestation). None of the fetuses who had recorded 226 
umbilical artery Doppler at the last scan ≤2 weeks before delivery (n=53) had abnormal 227 
parameters despite the majority (86%) with definite cord entanglement diagnosis. However, 228 
in one pregnancy with double IUD, there were normal Doppler parameters and no apparent 229 
knotting between the adjacent cords a week before IUDs were diagnosed. In all five 230 
pregnancies complicated by a major congenital anomaly the diagnosis was made by an 231 
antenatal ultrasound scan. The inter-twin discordance in the EFW at the last scan ≤2 weeks 232 
before delivery was a good predictor of the inter-twin birthweight discordance (regression 233 
coefficient [ß]=0.63, 95% CI=0.22-0.72, p=0.001) in an univariate model. The inter-twin 234 
birthweight discordance (>20%) was diagnosed in four pregnancies (9%). The vast majority 235 
(93.3%). of MCMA twins were delivered by caesarean section. Most twins (86.4%) were 236 
delivered at ≤34 weeks [median=33.0 (IQR=32.0-34.0) weeks; gestational age at delivery was 237 
insignificantly lower among the NorSTAMP patients [median=32.0 (IQR=31.0-34.0 vs 238 
STORK median=34.0 (IQR=32.5-34.0) weeks), p=0.061]. 239 
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Neonatal morbidity of MCMA twins (n=73 neonatal survivors) 240 
Five neonatal deaths were excluded from the analysis of neonatal morbidity (Table 4). Most 241 
twins (74% of 73 neonatal survivors) were admitted to SCBU for about 17 days with RDS as 242 
a most common diagnosis (58.7%) For infants with RDS, mechanical ventilation and/or 243 
CPAP were used for respiratory support in 15% and 55% of infants respectively.  244 
Discussion 245 
Summary of study findings 246 
We estimated the prevalence of MCMA twin pregnancies in an English region using 247 
population-based NorSTAMP data, 2000-2013, to inform future provision of obstetric and 248 
neonatal services. The total MCMA twin prevalence in the North of England was 8.2/1000 249 
twin pregnancies; the birth prevalence was 0.08/1000 all pregnancies. Over a third of 250 
pregnancies resulted in a spontaneous or iatrogenic IUD at <24 weeks of gestation (IUD rate 251 
31.8%). The overall perinatal mortality was 14.7%. The majority of MCMA twins were 252 
delivered by elective caesarean section at a median of 33 gestational weeks. The inter-twin 253 
birthweight discordance (>20%) was rare (9%). Neonatal morbidity was mostly associated 254 
with conditions related to preterm delivery, RDS being the most common diagnosis.  255 
Strengths and limitations 256 
This study used multicentre data sources from 10 STORK and 11 NorSTAMP maternity 257 
units. The NorSTAMP was unique in Europe by ascertaining a multiple pregnancy from the 258 
earliest antenatal scan. Accuracy of chorionicity diagnosis was ensured at the first trimester 259 
ultrasound scan by an experienced Fetal Medicine ultrasonographer in both the NorSTAMP 260 
and STORK tertiary centres. Only twin pregnancies with a definite MCMA diagnosis were 261 
included in the analysis. This study analysed early fetal losses in addition to perinatal 262 
outcomes, including congenital anomalies, and collected detailed antenatal data from the 263 
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serial ultrasound scans linked to the outcome data. In the North of England, congenital 264 
anomalies data were collected in the population-based NorCAS, linked with NorSTAMP, 265 
assuring completeness and accuracy of congenital anomaly data. Our study also has some 266 
limitations. The retrospective nature of the study led to challenges in obtaining all the 267 
necessary detail on the antenatal and neonatal data for all pregnancies in both collaborative 268 
centres, particularly for the early study years, resulting in incomplete follow up and some 269 
missing data. While both centres followed region-specific unified protocols for the 270 
management of MCMA twin pregnancies, consistent during the study period, there were some 271 
differences in relation to out- and in-patient antenatal management. Nevertheless, this did not 272 
significantly affect the timing of elective delivery, although gestational age at delivery was 273 
non-significantly lower among the NorSTAMP patients, possibly due to the RVI active 274 
management from about 28 weeks. Whilst detailed RVI antenatal scan data were extracted, 275 
full information regarding in/outpatient management and frequency of CTG monitoring was 276 
unavailable for all NorSTAMP pregnancies. Although one of the largest studies on MCMA 277 
twins in Europe, our sample size was still small.  278 
Interpretation of study findings and comparison with existing literature 279 
Females predominated in MCMA pairs with known fetal sex (67% from combined 280 
NorSTAMP and STORK data), consistent with previous studies,12,13,31-34 reporting a variation 281 
between 55%13-92%.34 The percentage of female MCMA pairs was significantly higher in the 282 
STORK cohort; likely due to a three-fold increased percentage of pregnancies with missing 283 
sex among early fetal losses (34.2% vs 10.6% in NorSTAMP), assuming a proposed higher 284 
rate of early fetal mortality among male MCMA pregnancies.31 Expected differences between 285 
the cohorts existed in maternal age and deprivation scores. Thus the reported higher maternal 286 
age in the STORK cohort can be attributed to the known geographical differences in maternal 287 
age distribution in England & Wales, characterised by the highest percentage of mothers aged 288 
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≥35 years in London (26.6% vs 15.1% in North East) and the two-fold higher percentage of 289 
younger mothers (<25 years) in the North East (2013 data).35 A significantly higher 290 
percentage of women from the most deprived residential areas were found in the NorSTAMP 291 
cohort as the North of England has a large proportion of areas amongst the most deprived in 292 
England.36 Our estimated MCMA twin prevalence of 0.8 per 10,000 all pregnancies in the 293 
North of England is consistent with published estimates.9 It is encouraging that in our study, 294 
as in the large recent study by Van Mieghem et al,16 MCMA pregnancies were diagnosed 295 
much earlier (at about 13 weeks‘ gestation) than in the past37 which gives more room for 296 
earlier fetal monitoring and management. Few studies reported pregnancy outcomes in 297 
MCMA pregnancies before 20 weeks gestation as the majority excluded early fetal losses 298 
from their analyses. The rate of spontaneous IUD (16.3%) in the above study16 was 299 
comparable with our study (23%, if excluding pregnancies with TRAP sequence as in the 300 
referred study). Pregnancies affected by a major congenital anomaly in our study constituted 301 
27%, similar to 23%16 and 28%37 in previous studies.  302 
Perinatal mortality in our study (14.7%) was almost identical to the total perinatal mortality 303 
reported by Baxi, 2010,34 for eight studies covering 1990-2007 (15%),12,32,33,37-41 being more 304 
similar (15%-19%) to larger multi-centre studies.12,39 Perinatal mortality for non-anomalous 305 
MCMA twins in our study (12.4%) was also similar to the total perinatal mortality for non-306 
anomalous pregnancies from six studies in their review (12.7%).34 Both perinatal (14.7%) and 307 
neonatal mortality (8.3%) in our study were comparable to those (19% and 10% respectively) 308 
from the biggest of the reviewed studies (n=92, Netherlands, 2000-200712), as well as to the 309 
perinatal mortality (13.9%) reported in a large recent Japanese study for 2002-2009 (n=101).13 310 
However, there are differences in the stillbirth definition between our and previous studies: 311 
≥24 weeks versus ≥2012,34,37 and ≥22 weeks’ gestation13 respectively. The use of an earlier 312 
stillbirth definition would have slightly increased our perinatal mortality rate. The largest 313 
14 
 
study on MCMA twins to date (2003-2012: 193 MCMA pregnancies, 295 live births)16 314 
reported neonatal mortality of 5.8% comparable with our study (8.3%).  315 
Clinical and research implications 316 
There is no consistency regarding optimal timing of elective delivery of MCMA twin 317 
pregnancies and the effect of cord entanglement on perinatal outcomes. Some authors 318 
advocate expectant management after 20 weeks, predicting a good prognosis for 319 
uncomplicated MCMA twin pregnancies despite the existence of cord entanglement.42,43 This 320 
would suggest reassessing the practice of elective very preterm delivery (≤32 weeks).42 There 321 
is evidence that IUD in MCMA twins can occur after 32 weeks,12,32,39,40 which is also 322 
confirmed by our findings. Whilst most MCMA pregnancies surviving beyond 24 weeks’ 323 
gestation with definite diagnosis of cord entanglement had good perinatal outcomes, the risk 324 
for fetal death after 32 weeks was shown to be 4 in 100 MCMA pregnancies compared to 1 in 325 
100 for neonatal death associated with preterm birth at 32 weeks.12,44 The largest study to date 326 
also demonstrated that the prospective risk of an IUD in MCMA twins outweighs the risk of a 327 
non-respiratory neonatal complication at 32 4/7 weeks of gestation concluding that optimal 328 
timing for elective delivery is about 33 gestational weeks.16  329 
 330 
Conclusions 331 
Our study confirms that the perinatal survival of MCMA twins has improved compared to 332 
previous decades presumably due to early diagnosis, careful fetal surveillance and elective 333 
birth by caesarean section at 32-34 weeks. Fetal losses at <24 weeks are common as a result 334 
of spontaneous loss and congenital anomalies. Future research investigating pregnancy 335 
outcomes and antenatal development of these rare high risk twin pregnancies should aim at a 336 
multicentre prospective approach to establish survival from the first trimester and the 337 
consequences of early elective delivery, including the long-term developmental outcomes.  338 
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Table 1. Baseline characteristics in monochorionic monoamniotic twin pregnancies, 504 
NorSTAMP and STORK, 2000-2013 505 
 NorSTAMP 
n=47 
STORK 
n=38 
P value 
Maternal age (y)* 27.0 (22.3-31.8) 30.5 (27.8-33.0) 0.035 
Maternal BMI at booking 
(kg/m2) 
24.1 (22.8-31.5)† 24.3 (22.5-28.3)† 0.53 
Most deprived quintile 
(IMD score) 
17/36 (47.2)† 4/37 (10.8) 0.001 
Female sex 24/42 (57.1) 21/25 (84.0) 0.03 
Nulliparous 23/42 (54.8) 22 (57.9) 0.82 
Prenatal diagnosis 47 (100.0) 38 (100.0) n/a 
Pregnancies affected by a 
major congenital anomaly‡ 
10 (21.3)  13 (34.2)  0.22 
Caesarean delivery§ 28/36 (77.8)§ 21/22 (95.5) 0.13 
Mann-Whitney U test was used for testing differences in distribution of continuous variables 506 
between the cohorts reporting medians (interquartile range, IQR), the Χ2 test (Fisher exact 507 
test) was used for testing differences in categorical variables reporting n (%). 508 
*Maternal age was recorded at delivery in NorSTAMP and at booking in STORK. 509 
†There were missing data in some variables (NorSTAMP: sex n=5; parity n=5; BMI n=16, 510 
IMD score n=11, maternal age n=3; STORK: BMI n=8)  511 
‡There were pregnancies where both twins were affected by a congenital anomaly: 512 
NorSTAMP – n=3, STORK – n=3.  513 
§Presented for pregnancies resulting in at least one registered birth: NorSTAMP: 8 women 514 
had spontaneous vertex delivery: 2 resulted in both antepartum stillbirths, three births were at 515 
<28 weeks of gestation: one at 22 and two at 26 weeks of gestation; and there were 3 516 
pregnancies with an early fetal loss: STORK: one pregnancy with a single antepartum 517 
stillbirth had a vaginal delivery.  518 
IMD=Index of multiple deprivation, an area-based measure of socio-economic position, based 519 
on the maternal residential postcode; quintile groups were calculated using the categories 520 
given in the IMD tool by the National Perinatal Epidemiology Unit (NPEU), University of 521 
Oxford https://tools.npeu.ox.ac.uk/imd/. Most deprived group was defined as the 5th quintile 522 
of the IMD score (≥34.18).523 
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Table 2. Pregnancy outcomes with causes of death of monochorionic monoamniotic twin pregnancies, NorSTAMP and STORK, 2000-2013 524 
a) Pregnancies with intrauterine death (IUD) at <24 weeks  525 
 n Cause/ 
Indication 
Co-twin 
Pregnancies with IUD at <24 weeks  
Live birth and IUD  3   
 1 TRAP, acardiac twin Alive at 12 months 
 1 TRAP, acardiac twin Alive at 12 months, VSD 
 1 PROM at 21+2wk, born at 25 wk - 
ENND (pulmonary immaturity)  
IUD at 23+2 wk, IUGR, placental insufficiency 
Double IUD (<16 wks) 11  
 4 Missed abortion 
 1 
1 
Double IUD at 14 wk, TTTS 
Double IUD at 11+6 wk 
 3 TRAP, acardiac twin IUD at 12-14 wk 
 2 Urinary anomaly IUD at 12-14 wk 
Double IUD (16-23 wks) 6 
1 
 
 
AP hypoxia at 21 wk 
 
 
pURSM sequence 
  1 Placenta insufficiency, placenta 
abruption, reverse EDF at 19+5 wk, 
IUD at 20+5 wk 
Placenta insufficiency, IUD at 17+5 wk 
 2 Double IUD (unexplained) at 19+2 wk and at 22 wk 
 1 TTTS at 23 wk 
 1 Unexplained IUD at 18wk 
TOP 7  
 1 Copper storage disorder (both twins) 
 1 Body stalk anomaly (both twins) 
 1 Body stalk anomaly  Bladder exstrophy  
 1 Increased NT Body stalk anomaly 
25 
 
 1 Amniotic bands  Orofacial cleft  
 2 No fetal anomaly (either twin) 
    
Selective feticide and live birth 3   
  1 Encephalocele  Alive at 12 months 
 1 Multiple anomalies (spina bifida, 
exomphalos) 
Alive at 28 days 
 1 Hydrocephalus Alive at 28 days 
Total  30   
 526 
b) Live births and pregnancies with IUD at ≥24 weeks 527 
 n 
deaths 
Cause/ 
Indication 
Co-twin 
Live births and pregnancies with IUD at ≥24 weeks  
Double AP stillbirths 2   
 1 Unexplained AP hypoxia at 24 wk (both twins) 
 1 AP hypoxia due to cord entanglement* at 32 wk (both twins) 
Live birth and IUD 4   
 1 AP hypoxia due to cord entanglement* (27 wk) Alive at 12 months 
 3 AP hypoxia Alive at 28 days 
    
Both live births 49   
    
Both survived first 28 days 43 n/a n/a 
Single neonatal death    
 1 Diaphragmatic hernia, secondary 
hypoplasia of lungs (delivered at 34 wk) 
Alive at 12 months 
 2 CHD  Alive at 28 days 
 1 HMD, extensive IVH, sepsis, seizures, 
renal failure (26 wk) 
HMD, alive at 12 months 
Both neonatal deaths    
26 
 
 1 Extreme prematurity (26 wk), HMD, 
complex CHD  
Extreme prematurity, HMD, IVH 
 1 Extreme prematurity (22 wk), severe HMD (both twins) 
Total  55   
Table footnote: pregnancies with conjoined twins are not included  528 
*This cause of death was specified if the definite post-mortem diagnosis was available.  529 
AP = antepartum, IUD = intrauterine death; TOP = termination of pregnancy, NT = nuchal translucency; pURSM sequence = Partial urorectal 530 
septum malformation sequence (or ‘persistent cloaca’); TTTS= twin-twin transfusion syndrome; EDF = end-diastolic flow on umbilical artery 531 
Doppler; ENND= early neonatal death; HMD = hyaline membrane disease; CHD =Congenital heart disease, IVH = intraventricular 532 
haemorrhage.  533 
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Table 3. Perinatal mortality with cause of death in monochorionic monoamniotic (MCMA) 534 
twin pregnancies, NorSTAMP and STORK, 2000-2013 535 
 
Cause of death 
Stillbirth* 
n (rate per 1000 
total twin births) 
Neonatal death 
n (rate per 1000 
twin live births) 
Perinatal death† 
n (rate per 1000 
total twin births) 
Congenital anomaly  4 (37.0) 4 (34.5) 
Antepartum hypoxia 
(cord entanglement n=3) 
8 (69.0)  8 (69.0) 
Prematurity‡  5 (46.3) 5 (43.1) 
Total 8 (69.0) 9 (83.3)§ 17 (146.6) 
Total MCMA twins (n) 116 108 116 
*Stillbirth rate is calculated per 1000 registered births in MCMA twin maternities, excluding 536 
single fetal losses at <24 weeks of gestation (n=6) in pregnancies resulting in a single live 537 
birth.  538 
†Perinatal deaths include stillbirths (≥24 weeks of gestation) and neonatal (0-27 days) deaths. 539 
‡Prematurity category includes related cause codes: severe pulmonary immaturity, hyaline 540 
membrane disease and intraventricular haemorrhage. 541 
§Four pregnancies resulted in neonatal deaths at <27 weeks of gestation: two co-twins at 22 542 
weeks of gestation (both early neonatal deaths, ENNDs), one ENND at 25 weeks, two co-543 
twins (ENND with complex congenital heart disease and late neonatal death due to severe 544 
hyaline membrane disease) and one single late neonatal death at 26 weeks. 545 
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Table 4. Antenatal parameters and obstetric and neonatal outcomes of monochorionic 546 
monoamniotic (MCMA) twins, NorSTAMP and STORK, 2000-2013 547 
Antenatal parameters (45 pregnancies: 5 stillbirths and 85 live births) 
Gestational age at US chorionicity diagnosis  
median (IQR) 
 
13.0 (12.0-14.0) 
Estimated fetal weight (EFW)  n=25 median (IQR)*  
The smaller twin 1711.0 (1443.5-1910.5)  
The bigger twin 1850.0 (1580.5-2070.0) 
SGA based on EFW (<10 percentile†) n % 1 (4.0) 
Inter-twin EFW discordance   median (IQR) (%) 6.8 (3.3-16.5) 
sGR (EFW discordance (>20%)   n (%) 5 (20.0) 
Diagnosis of TTTS n (%) 2/45 (4.9) 
Definite diagnosis of cord entanglement n (%)‡ 40/44 (90.1) 
Diagnosis of inter-twin growth discordance n (%) 2/45 (4.4) 
Antenatal diagnosis of a major congenital anomaly n fetuses 
(%) 
5/90 (5.6) 
Evidence of abnormal Doppler parameters at the last scan* n 
fetuses (%) 
0/53 (0.0) 
Obstetric outcomes (45 pregnancies: 5 stillbirths and 85 live births) 
Elective CS n (%) 33 (73.3) 
Emergency CS n (%) 9 (20.0) 
Gestational age at delivery n=44 median (IQR) 33 (32-34) 
<34 weeks n deliveries (%) 25 (56.8) 
<32 weeks n deliveries (%) 7 (15.9) 
<30 weeks n deliveries (%) 2 (4.5) 
Birthweight median  n=44 (IQR) (g)  
The smaller twin 1800 (1542.3-2004.5) 
The bigger twin 1964.5 (1659.5-2150.3) 
SGA (<10 percentile)† n % 4/86 (4.7) 
Inter-twin birthweight discordance median (IQR) (%) 6.4 (1.9-12.8) 
Inter-twin birthweight discordance (>20%) n % 4 (9.1) 
Birthweight discordance (>15%) n % 8 (18.2) 
Neonatal death n (% of live births) 5 (5.9) 
Pregnancies complicated by a major congenital anomaly n % 5 (11.1) 
Resulting in neonatal death with  
congenital anomaly as a major cause 
3 (6.7)  
Neonatal outcomes (n=73 neonatal survivors)§ 
Admitted to SCBU n (%) 54 (74.0) 
Days at SCBU   
Twin 1     median (IQR)¶ 18.5 (6.0-28.3) 
Twin 2     median (IQR)¶ 16.5 (6.0-35.0) 
Mechanical ventilation n (%) 11 (15.1) 
CPAP n (%)$ 23/42 (54.8) 
Respiratory distress syndrome    n (%) $ 27/46 (58.7) 
Necrotising enterocolitisf            n (%) $ 1/55 (1.8) 
Sepsis (confirmed or suspected/treated with antibiotics) n (%)$ 2/55 (3.6) 
Intraventricular haemorrhage     n=36 (%)$ 0 (0.0) 
29 
* Only estimated fetal weights (EFW) and Doppler parameters examined at gestational age of 548 
2 weeks or less prior to delivery are included. 549 
† Birthweight <10th percentile was calculated to define small for gestational age (SGA) 550 
infants using birthweight-by-gestation and sex standards from a population of Scottish 551 
twins;23 EFW <10th percentile was calculated to define SGA in utero using fetal growth 552 
curves from the USA ultrasound data24 adjusted to fit the Scottish reference dataset.23 553 
‡ In one pregnancy resulting in both early neonatal deaths (22 wks of gestation) there was no 554 
comment on cord conditions. 555 
§ STORK pregnancies with missing data on neonatal outcomes are excluded (n=4). 556 
¶ missing data for 7 of 29 1st twins and for 9 of 25 2nd twins admitted to SCBU.  557 
$Calculated using complete data for this parameter. 558 
CS=caesarean section; CPAP=continuous positive airway pressure; SCBU=Special Care 559 
Baby Unit; sFGR= selective fetal growth restriction defined as difference in EFW of greater 560 
than 20%.10 561 
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Figure legends 562 
Figure 1. Derivation of the study cohort of monochorionic monoamniotic (MCMA) twin 563 
pregnancies using population-based North of England data from the Northern Survey of Twin 564 
and Multiple Pregnancy (NorSTAMP) and data from the multicentre Southwest Thames 565 
Region of London Obstetric Research Collaborative (STORK) multiple birth cohort, 2000-566 
2013  567 
Figure 1 footnote:  568 
*Pregnancies with conjoined twins are excluded (n=12 in NorSTAMP, n=4 in STORK); 569 
IUD=intrauterine death; TOPFA= termination of pregnancy for fetal anomaly. 570 
Maternities are defined as pregnancies with at least one live birth or stillbirth (fetal death at 571 
≥24 weeks of gestation), including pregnancies with one early fetal loss. 572 
 573 
Figure S1. Principles of active management of patients with monochorionic monoamniotic 574 
(MCMA) pregnancy in the Department of Fetal Medicine, Royal Victoria Infirmary (RVI), 575 
Newcastle upon Tyne  576 
31 
Figure 1. Derivation of the study cohort of monochorionic monoamniotic (MCMA) twin 577 
pregnancies using population-based North of England data from the Northern Survey of Twin 578 
and Multiple Pregnancy (NorSTAMP) and data from the multicentre Southwest Thames 579 
Region of London Obstetric Research Collaborative (STORK) multiple birth cohort, 2000-580 
2013  581 
 582 
 583 
Figure footnote:  584 
*Pregnancies with conjoined twins are excluded (n=12 in NorSTAMP, n=4 in STORK); 585 
IUD=intrauterine death; TOPFA= termination of pregnancy for fetal anomaly. 586 
Maternities are defined as pregnancies with at least one live birth or stillbirth (fetal death at 587 
≥24 weeks of gestation), including pregnancies with one early fetal loss. 588 
 589 
32 
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(MCMA) pregnancy in the Department of Fetal Medicine, Royal Victoria Infirmary (RVI), 591 
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